Article | April 8, 2024

The Quest For Sterility Assurance: A New Approach To Isolator Decontamination

Source: AST

How can you address the decontamination challenges associated with isolated fill-finish operations? Meeting the sterility and regulatory thresholds in pharmaceutical manufacturing is a critical process. Conventional decontamination methods, predominantly utilizing high concentrations of hydrogen peroxide, present challenges regarding efficacy, residue, and operational downtime. A new innovation being explored, involves the implementation of low-concentration Vapor Phase Hydrogen Peroxide (VPHP) with patented Pulse™ technology, ensuring superior sporicidal reduction and operational safety. Here we explore this forward-looking approach to sterile parenteral drug manufacturing and solutions being used to reduce decontamination cycle time while maintaining sterility assurance and meeting industry demands effectively.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online